Featured In Neuroscience
New immunotherapy for brain cancer tackles the barrier of tumor heterogeneity using a home-grown combination of CAR T-cell therapy and bispecific antibodies.
Featured In Digestive Health
Researchers at the Massachusetts General Hospital Alcohol Liver Center found that substance use disorder, especially opioid use disorder, is a key modifiable risk factor for alcohol-associated liver disease in patients with alcohol use disorder.
Featured In Cardiovascular
Aneesh Bapat, MD, David Milan, MD, Saumya Das, MD, PhD, and colleagues demonstrated in a mouse model that genetic inhibition of serum glucocorticoid kinase 1 (SGK1) prevents some of the atrial fibrillation risk associated with diet-induced obesity, suggesting SGK1 is an attractive potential therapeutic target.
The study involves multiple visits over 6 months. You will complete an 8-week stress reduction treatment that includes a medical device worn in the ear and attend MRI and PET scans. You will also complete daily migraine diaries online.
We are seeking individuals who self-identify as having high stress to participate in a randomized study using a mindfulness-based, stress-reduction intervention and PET-MR imaging.